West Pharmaceutical Services, Inc.
WSTHealthcareNASDAQMedical Instruments & Supplies
Scan Results
Daily timeframeHeadquartered within the healthcare sector, West Pharmaceutical Services, Inc. focuses on Medical Instruments & Supplies services and products. West Pharmaceutical Services, Inc. At a $25.31B market cap, West Pharmaceutical Services, Inc. ranks as a large-cap company within healthcare. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.
Market Cap
$25.31B
Beta
1.16
P/E (TTM)
47.96
P/E (Fwd)
37.24
EPS (TTM)
$7.47
EPS (Fwd)
$9.62
ROE
19.1%
ROA
11.2%
Cash
$521.4M
Total Debt
$321.0M
Free CF
$275.7M
52W Change
69.9%
Annual Financials
Cash vs Debt
West Pharmaceutical Services, Inc. holds $521.4M in cash against $321.0M in total debt, giving it a net cash position. This means the company could theoretically pay off all its debt and still have cash remaining. Free cash flow comes in at $275.7M, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. Return on equity stands at 19.1%, which is strong for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. Return on assets of 11.2% further supports the picture of efficient asset utilization. Revenue has been relatively flat, moving from $2.89B (2022) to $3.07B (2025).
As with any equity investment, WST carries market risk, sector-specific risk, and company-specific risk that investors should evaluate in the context of their own portfolios. It is important to consider these factors alongside broader market conditions and individual financial goals when reviewing WST.